Market news

Healthcare Triangle (NASDAQ:HCTI) has signed a non-binding letter of intent for a proposed Roboticom acquisition valued at up to $30 million, potentially expanding the healthcare technology company into industrial robotics and precision automation. Key Investor TakeawaysHealthcare Triangle (NASDAQ:HCTI) signed a non-binding LOI to acquire specified Roboticom customer contracts, intellectual property, trademarks and business assets.

Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company") today announced it has signed a non-binding Letter of Intent ("LOI") with Crestpoint Capital LLC ("Seller") outlining a proposed transaction in which HCTI would acquire certain intellectual property, trademarks and business assets associated with Roboticom (roboticom.it), a Pisa, Italy-based provider of industrial robotic automation systems for precision surface treatment, marketed under the SandRob™, ORTIS™ and ScultoRob™ produc

Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a U.S.-based healthcare technology company, today announced that it has signed on as the U.S. technology and capital-markets partner for a new fund built to move Malaysian healthcare companies to the world stage. The Kanzun-ARCB Growth Fund launched through a Memorandum of Understanding signed in Kuala Lumpur, Malaysia, pairing Dubai-based ARCB Investment LLC's ("ARCB") capital network with Kanzun Ventures Management Sdn. Bhd.'s

By Brad Sorensen, CFA NASDAQ: HCTI Healthcare Triangle’s (NASDAQ: HCTI) planned spin-off of Teyame AI Holdings represents an interesting new chapter in the company’s transformation. Rather than simply selling the rapidly growing AI-powered customer engagement operation that has become an increasingly important part of Healthcare Triangle, or HCTI, management is pursuing a structure that could

Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a healthcare technology company delivering cloud, digital transformation, and data-driven solutions to healthcare and life sciences organizations, including AI-powered customer engagement services delivering AI-powered customer engagement and digital transformation services, today announced that it has signed a separation agreement (the "Separation Agreement") with its subsidiary Teyame AI Holdings Inc. ("Teyame AI Holdings") se

Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a technology company delivering AI-powered customer engagement and digital transformation services, is today reporting financial results for the second quarter ended June 30, 2026, which includes second quarter revenue of $9.19 million, up 158% year over year, with gross profit up 322% to $2.07 million. The Company's AI platform delivered roughly 69% of quarterly revenue and drove gross margin to 22.5% from 13.8%.

Detailed price information for Healthcare Triangle Inc (HCTI-Q) from The Globe and Mail including charting and trades.

Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations, today reported that, on July 24, 2026, it completed the issuance of an aggregate of 12,546,540 shares of common stock in connection with two previously shareholder-approved transactions: the closing of its acquisition involving Teyame AI LLC and related parties (the "Teyame Transaction")

Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for the healthcare and life sciences industries, today announced it has signed a non-binding Letter of Intent (LOI) to acquire a 51% equity stake in CosmoAesthetics Pty Ltd. Operating under the brand CosmoInnovations, the Melbourne, Australia-based company is a premier innovator in MedTech, BeautyTech, and consumer-health products.

By Brad Sorensen, CFA NASDAQ: HCTI READ THE FULL HCTI RESEARCH REPORT Healthcare Triangle (NASDAQ: HCTI) has taken another meaningful step in our view in advancing its long-term growth strategy through a series of recently announced transactions that are designed to complete and strengthen several strategic acquisitions while simplifying its capital structure. Although the recently announced

Healthcare Triangle, Inc. (NASDAQ: HCTI), a healthcare and life sciences technology company enabling digital transformation through cloud, data, artificial intelligence, and security solutions, today announced that proven industry executive Sumit Ganguli has been appointed Chairman and Chief Executive Officer of Purpose Health, Inc., HCTI's wholly owned, AI-led healthcare technology services subsidiary.